The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab and consolidation SBRT following chemoradiation for stage III non-small cell lung cancer: A single institution pilot study.
 
Paul Koffer
No Relationships to Disclose
 
Hetal Mistry
Employment - Regeneron (I)
Stock and Other Ownership Interests - Regeneron (I)
 
Jaroslaw T. Hepel
No Relationships to Disclose
 
Thomas A. DiPetrillo
Patents, Royalties, Other Intellectual Property - Patent for brachytherapy device
 
Roxanne Wood
No Relationships to Disclose
 
Vallerie Rosati
No Relationships to Disclose
 
Ariel E. Birnbaum
No Relationships to Disclose
 
Christopher G. Azzoli
Research Funding - Bristol Myers Squibb
 
Humera Khurshid
No Relationships to Disclose
 
Hina Khan
Consulting or Advisory Role - Genzyme
Research Funding - Robert A. Winn Diversity in Clinical Trials Award Program